Annual Results Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
EQUITY AND LIABILITIES
No of Months
12
12
12
Share Capital
4.03
4.03
3.28
Share Warrants & Outstandings
Total Reserve
27.38
18.63
2.94
Shareholder's Funds
31.41
22.66
6.23
Minority Interest
0.00
0.00
0.00
Long-Term Borrowings
13.23
9.85
7.28
Secured Loans
12.93
9.85
7.28
Unsecured Loans
0.30
0.00
0.00
Deferred Tax Assets / Liabilities
0.15
0.07
-0.01
Other Long Term Liabilities
0.16
0.24
0.22
Long Term Trade Payables
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
Total Non-Current Liabilities
13.54
10.16
7.49
Current Liabilities
Trade Payables
9.47
7.27
5.55
Other Current Liabilities
4.40
4.01
7.42
Short Term Borrowings
15.71
12.31
7.85
Short Term Provisions
0.00
0.00
0.00
Total Current Liabilities
29.58
23.59
20.81
Total Liabilities
74.53
56.41
34.53
ASSETS
Non-Current Assets
0.00
0.00
0.00
Gross Block
20.12
15.95
12.66
Less: Accumulated Depreciation
4.06
2.85
2.41
Less : Impairment of Assets
0.00
0.00
0.00
Net Block
16.06
13.10
10.25
Lease Adjustment
0.00
0.00
0.00
Capital Work in Progress
12.85
4.62
0.03
Intangible assets under development
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
Non Current Investments
0.03
0.03
0.03
Long Term Loans & Advances
2.05
1.11
0.58
Other Non Current Assets
0.52
0.53
0.75
Total Non-Current Assets
31.37
19.24
11.49
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
Inventories
17.18
13.07
12.40
Sundry Debtors
21.02
17.21
8.09
Cash and Bank
2.93
4.94
0.36
Other Current Assets
0.15
0.09
0.06
Short Term Loans and Advances
1.89
1.86
2.14
Total Current Assets
43.16
37.17
23.04
Net Current Assets (Including Current Investments)
13.58
13.58
2.23
Total Current Assets Excluding Current Investments
43.16
37.17
23.04
Miscellaneous Expenses not written off
0.00
0.00
0.00
Total Assets
74.53
56.41
34.53
Contingent Liabilities
0.37
0.37
0.00
Total Debt
28.93
22.16
0.00
Book Value per share (adjusted)
77.92
56.21
18.96
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 30.55% vs 46.46% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is -33.33% vs 9.09% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 63.15% vs 72.37% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 16.12% vs 61.33% in Mar 2025
Compare Balance Sheet Results of Avience Biomedi.
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.03
14.79
-10.76
-72.75%
Share Warrants & Outstandings
Total Reserve
27.38
16.21
11.17
68.91%
Shareholder's Funds
31.41
31.00
0.41
1.32%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
13.23
0.00
13.23
0.00%
Secured Loans
12.93
0.00
12.93
0.00%
Unsecured Loans
0.30
0.00
0.30
0.00%
Deferred Tax Assets / Liabilities
0.15
0.00
0.15
0.00%
Other Long Term Liabilities
0.16
0.00
0.16
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
13.54
0.00
13.54
0.00%
Current Liabilities
Trade Payables
9.47
1.29
8.18
634.11%
Other Current Liabilities
4.40
3.73
0.67
17.96%
Short Term Borrowings
15.71
0.00
15.71
0.00%
Short Term Provisions
0.00
0.22
-0.22
-100.00%
Total Current Liabilities
29.58
5.24
24.34
464.50%
Total Liabilities
74.53
36.24
38.29
105.66%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
20.12
0.03
20.09
66,966.67%
Less: Accumulated Depreciation
4.06
0.03
4.03
13,433.33%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
16.06
0.00
16.06
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
12.85
0.00
12.85
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.03
0.00
0.03
0.00%
Long Term Loans & Advances
2.05
12.48
-10.43
-83.57%
Other Non Current Assets
0.52
0.00
0.52
0.00%
Total Non-Current Assets
31.37
12.48
18.89
151.36%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
17.18
0.00
17.18
0.00%
Sundry Debtors
21.02
0.22
20.80
9,454.55%
Cash and Bank
2.93
0.28
2.65
946.43%
Other Current Assets
0.15
5.04
-4.89
-97.02%
Short Term Loans and Advances
1.89
18.23
-16.34
-89.63%
Total Current Assets
43.16
23.77
19.39
81.57%
Net Current Assets (Including Current Investments)
13.58
18.53
-4.95
-26.71%
Total Current Assets Excluding Current Investments
43.16
23.77
19.39
81.57%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
74.53
36.24
38.29
105.66%
Contingent Liabilities
0.37
0.00
0.37
0.00%
Total Debt
28.93
0.00
28.93
0.00%
Book Value per share (adjusted)
77.92
2.10
75.82
3,610.48%
Annual - Borrowings
Borrowings 28.93 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 30.55% vs 46.46% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -33.33% vs 9.09% in Mar 2025
Annual - Fixed Assets
Fixed Assets 28.91 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 63.15% vs 72.37% in Mar 2025
Annual - Investments
Investments 0.03 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 43.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 16.12% vs 61.33% in Mar 2025
Footer loading
